Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Change in Accured Expenses (2018 - 2025)

Neurogene's Change in Accured Expenses history spans 6 years, with the latest figure at $1.3 million for Q4 2025.

  • For Q4 2025, Change in Accured Expenses rose 279.14% year-over-year to $1.3 million; the TTM value through Dec 2025 reached $1.7 million, up 160.04%, while the annual FY2025 figure was $1.7 million, 160.04% up from the prior year.
  • Change in Accured Expenses reached $1.3 million in Q4 2025 per NGNE's latest filing, up from $365000.0 in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $2.6 million in Q3 2024 to a low of -$4.9 million in Q1 2024.
  • Average Change in Accured Expenses over 3 years is -$390166.7, with a median of $286000.0 recorded in 2024.
  • Peak YoY movement for Change in Accured Expenses: crashed 99.63% in 2024, then skyrocketed 949.28% in 2025.
  • A 3-year view of Change in Accured Expenses shows it stood at -$3.7 million in 2023, then surged by 79.71% to -$743000.0 in 2024, then soared by 279.14% to $1.3 million in 2025.
  • Per Business Quant, the three most recent readings for NGNE's Change in Accured Expenses are $1.3 million (Q4 2025), $365000.0 (Q3 2025), and $2.2 million (Q2 2025).